Objective The objective is to summarize the knowledge on the epidemiology,
pathophysiology and management of secondary headache attributed to SARS-CoV-2 …

Background Series of patients with SARS‐CoV‐2 infection report headache in 6%‐15% of
cases, although some data suggest that the actual frequency is higher, and that headache is …

Objective To review data regarding the epidemiology, pathophysiology, characteristics, and
management of COVID‐19–associated headache. The persistence of headache after the …

Abstract Purpose of Review Post-COVID headache may be unique in presentation and
mechanism, often presenting as a new phenotype in patients with a history of a primary …

Abstract Purpose of Review Headache is a common symptom of COVID-19 with emerging
literature being published on the subject. Although it may seem unspecific, scientific …

Background Coronavirus disease-19 is caused by the severe acute respiratory syndrome
coronavirus 2 Headache is a common symptom during and after Coronavirus disease-19 …

Background and purpose Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection can exacerbate previous headache disorders or change the type of pain …

Background Headache can be a prominent feature of Post‐Acute Sequelae of SARS‐Cov2
infection (PASC) and previous studies have centered around PASC headaches that have …

Background and purpose The aim was to provide insights to the characteristics of headache
in the context of COVID‐19 on behalf of the Headache Scientific Panel and the Neuro …

Since December 2019, the time when the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was spotted, numerous review studies have been published on COVID-19 …